At a glance
- Learn more about the reports from the National ALS Registry Annual Meeting. The meeting shares the findings of the Registry data and its implications and to discuss strategies to further improve the Registry. Attendees include neurologists who specialize in the diagnosis and treatment of ALS, researchers, patients, members of ALS advocacy groups, the National ALS Registry staff, and others interested in ALS research.
Old Reports
- 2020 ALS-Annual-Meeting-Summary-Report-Executive-Summary
- 2020 ALS-Annual-Meeting-Summary-Report
- 2019 ALS-Annual-Meeting-Summary-Report-Executive-Summary
- 2019 ALS-Annual-Meeting-Summary-Report
- 2018-ALS-Annual-Meeting-Summary-Report-Executive-Summary
- 2018 ALS Annual Meeting Summary Report
- 2017-ALS-Annual-Meeting-Summary-Report-Executive-Summary
- 2017 ALS Annual Meeting Summary Report
- 2016 ALS Annual Meeting Summary Report Executive Summary
- 2016 ALS Annual Meeting Summary Report
- 2015 ALS Annual Meeting Summary Report Executive Summary
- 2015 ALS Annual Meeting Summary Report
- 2014 ALS Annual Meeting Summary Report
- 2014 ALS Annual Meeting Summary Report Executive Summary
- 2013 ALS Annual Meeting Summary Report
- 2013 ALS Annual Meeting Summary Report Executive Summary
- 2012 ALS Annual Meeting Summary Report
- 2011 ALS Annual Meeting Summary Report
- 2010 ALS Annual Meeting Summary Report
- 2009 ALS-MS Annual Meeting Summary Report
- 2008 ALS-MS Annual Meeting Summary Report
- 2007 ALS-MS Annual Meeting Summary Report
- 2006 ALS-MS Annual Meeting Summary Report
Content Source:
Agency for Toxic Substances and Disease Registry